These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 21791513

  • 1. Non-cardiac surgery in patients with coronary stents: the RECO study.
    Albaladejo P, Marret E, Samama CM, Collet JP, Abhay K, Loutrel O, Charbonneau H, Jaber S, Thoret S, Bosson JL, Piriou V.
    Heart; 2011 Oct; 97(19):1566-72. PubMed ID: 21791513
    [Abstract] [Full Text] [Related]

  • 2. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG, Qu Y, Shen H, Liu XH.
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [Abstract] [Full Text] [Related]

  • 3. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP, Lawler E, Young M, Gaziano M, Kinlay S.
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [Abstract] [Full Text] [Related]

  • 4. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.
    Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):395-405. PubMed ID: 22109961
    [Abstract] [Full Text] [Related]

  • 5. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
    Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.
    Circ Cardiovasc Interv; 2012 Jun 01; 5(3):381-91. PubMed ID: 22619260
    [Abstract] [Full Text] [Related]

  • 6. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, Mehilli J, von Beckerath N, Schömig A, Kastrati A, Sibbing D.
    Thromb Haemost; 2010 Dec 01; 104(6):1193-200. PubMed ID: 20838744
    [Abstract] [Full Text] [Related]

  • 7. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 01; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial.
    Collet JP, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Hu TF, Johnston SC, Hamm CW, Bhatt DL, Topol EJ.
    Arch Cardiovasc Dis; 2009 Dec 01; 102(6-7):485-96. PubMed ID: 19664568
    [Abstract] [Full Text] [Related]

  • 9. Real-life management of dual antiplatelet therapy interruption: the REGINA survey.
    Collet JP, Aout M, Alantar A, Coriat P, Napoléon B, Thomas D, Trosini-Desert V, Tucas G, Vicaut E, Montalescot G.
    Arch Cardiovasc Dis; 2009 Oct 01; 102(10):697-710. PubMed ID: 19913771
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
    Persson J, Lindbäck J, Hofman-Bang C, Lagerqvist B, Stenestrand U, Samnegard A.
    EuroIntervention; 2011 Apr 01; 6(9):1046-52, 8-9. PubMed ID: 21518675
    [Abstract] [Full Text] [Related]

  • 11. Frequency and risk of noncardiac surgery after drug-eluting stent implantation.
    Gandhi NK, Abdel-Karim AR, Banerjee S, Brilakis ES.
    Catheter Cardiovasc Interv; 2011 Jun 01; 77(7):972-6. PubMed ID: 20824750
    [Abstract] [Full Text] [Related]

  • 12. Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.
    Lemesle G, Torguson R, Bonello L, de Labriolle A, Maluenda G, Ben-Dor I, Collins SD, Syed AI, Xue Z, Satler LF, Pichard AD, Waksman R.
    EuroIntervention; 2011 Apr 01; 6(9):1053-9. PubMed ID: 21518676
    [Abstract] [Full Text] [Related]

  • 13. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
    Rubboli A, Milandri M, Castelvetri C, Cosmi B.
    Cardiology; 2005 Apr 01; 104(2):101-6. PubMed ID: 16020950
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 01; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 15. General thoracic surgery is safe in patients taking clopidogrel (Plavix).
    Cerfolio RJ, Minnich DJ, Bryant AS.
    J Thorac Cardiovasc Surg; 2010 Nov 01; 140(5):970-6. PubMed ID: 20804992
    [Abstract] [Full Text] [Related]

  • 16. Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.
    Ambrosio G, Steinhubl S, Gresele P, Tritto I, Zuchi C, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Mehran R, Stone GW.
    Eur J Cardiovasc Prev Rehabil; 2011 Feb 01; 18(1):121-8. PubMed ID: 20523219
    [Abstract] [Full Text] [Related]

  • 17. Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.
    Sangiorgi GM, Morice MC, Bramucci E, Ferlini M, Grinfeld L, Petronio AS, Pierli C, Iadanza A, Biondi-Zoccai G, Colombo A.
    EuroIntervention; 2011 Nov 01; 7(7):813-9. PubMed ID: 22082577
    [Abstract] [Full Text] [Related]

  • 18. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
    Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Harmsze AM, Hackeng CM, ten Berg JM.
    Heart; 2011 Jun 01; 97(12):983-90. PubMed ID: 21478385
    [Abstract] [Full Text] [Related]

  • 19. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM, Claeys MJ, Haine S, Miljoen H, Bosmans JM, Vertessen F, Kluppels K, Van der Planken M, Vrints CJ.
    Am Heart J; 2010 Mar 01; 159(3):434-8. PubMed ID: 20211306
    [Abstract] [Full Text] [Related]

  • 20. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J, Mahmoody Y, Zangbar Sabegh B, Jannati M, Mahboodi A, Khalili A.
    Cardiovasc Ther; 2010 Jun 01; 28(3):147-52. PubMed ID: 20557313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.